Godavari Drugs Ltd — Board Meeting, 29-05-2025: Board Meeting

Godavari Drugs Limited has announced a board meeting outcome approving the audited financial results for the quarter and financial year ended March 31, 2025, with the auditor’s report issuing an unmodified opinion. Two Independent Directors will retire after completing their second five-year terms, leading to a reconstitution of key board committees. Mrs. Shilpa Bung has been appointed as an Additional Independent Director for five years, subject to shareholder approval. The board has appointed new internal auditors, secretarial auditors (for five years), and cost auditors (for FY 2025-26). The 37th Annual General Meeting will be held via video conference. No defaults on loans or debt securities were reported.